Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success
{{output}}
The new National Institute for Health and Care Excellence (NICE) guidance on the use of dupilumab in chronic obstructive pulmonary disease (COPD) recommends using dupilumab as an add-on therapy for patients with uncontrolled COPD and raised blood eosinophils w... ...
